risky bez logowania
/ 83.27.138.* / 2007-09-05 14:48
Property Fund of Ukraine decided to abandon the privatization of the largest domestic manufacturer of insulin-company Indar. As a result, the value of shares of the biotechnology firm Polish Bioton, which was intended to acquire Ukrainian company, a one-day fell by 6%.
MFI supported project to the Cabinet, excluding 70.7% stake in the company Indar "from the list of privatized in 2007. "Privatizirovat venture inappropriate, as it provides job-state production of insulin," said correspondent for the newspaper "CASE" in the press service said. They explained that the initiator of exclusion from the list of privatization has been the Ministry of Health. "We tend to support such proposals," said the press service of the Fund.
The press service of Ministry of Health explained that the existence of the plant in Ukraine "Indar allows annual savings of more than 20 million hryvnas. "The company needs to insulin in the country at lower prices than other manufacturers. Ministry always has influence on the pricing policy "Indara", "said the press service. The Ministry believes that if necessary, the State would be able to find investments for the development of enterprises.